Valuation Vertex Pharmaceuticals Incorporated

Stocks

Real-time Estimate Cboe BZX Other stock markets 22:51:20 29/06/2026 HKT			5-day change	1st Jan Change
495.54 ^USD	+0.85%		+6.29%	+9.44%

03:23pm	Vertex Pharmaceuticals Incorporated(NasdaqGS:VRTX) added to Russell 1000 Value Benchmark	CI
11:45am	Vertex Pharmaceuticals Incorporated(NasdaqGS:VRTX) dropped from Russell 3000E Growth Benchmark	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	55,834	74,127	104,849	103,707	115,026	124,705	-	-
Change	-	32.76%	41.44%	-1.09%	10.91%	8.41%	-	-
Enterprise Value (EV) ¹	48,309	63,349	93,630	97,591	108,418	111,920	107,570	103,203
Change	-	31.13%	47.8%	4.23%	11.09%	3.23%	-3.89%	-4.06%
P/E	24.4x	22.5x	29.3x	-194x	29.6x	28.1x	24.9x	21.3x
PBR	5.53x	5.33x	5.96x	6.4x	6.17x	5.64x	4.7x	3.96x
PEG	-	0.5x	3.51x	2x	-0x	2x	2x	1.3x
Capitalization / Revenue	7.37x	8.3x	10.6x	9.41x	9.58x	9.56x	8.74x	7.87x
EV / Revenue	6.38x	7.09x	9.49x	8.86x	9.03x	8.58x	7.54x	6.52x
EV / EBITDA	10.8x	12.8x	20.6x	108x	19.8x	19.4x	16.2x	13.5x
EV / EBIT	11.1x	13.2x	21.4x	140x	20.6x	20.2x	17x	14.1x
EV / FCF	20.1x	16.1x	28.1x	-123x	33.9x	23.1x	20.9x	18.3x
FCF Yield	4.99%	6.2%	3.56%	-0.81%	2.95%	4.33%	4.78%	5.47%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	9.01	12.82	13.89	-2.08	15.32	17.49	19.71	23.03
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	7,574	8,931	9,869	11,020	12,001	13,038	14,267	15,840
EBITDA ¹	4,470	4,941	4,556	902.8	5,473	5,782	6,651	7,618
EBIT ¹	4,344	4,793	4,375	695.6	5,263	5,554	6,319	7,333
Net income ¹	2,342	3,322	3,620	-535.6	3,953	4,451	5,053	5,979
Net Debt ¹	-7,525	-10,778	-11,218	-6,116	-6,608	-12,785	-17,134	-21,501
Reference price ²	219.60	288.78	406.89	402.70	453.36	491.34	491.34	491.34
Nbr of stocks (in thousands)	254,252	256,691	257,683	257,529	253,719	253,805	-	-
Announcement Date	26/1/22	7/2/23	5/2/24	10/2/25	12/2/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
VERTEX PHARMACEUTICALS INCORPORATED	28.09x	8.58x	19.36x	-.--%	125B
ELI LILLY AND COMPANY	35.2x	12.84x	26.1x	0.57%	1,077B
JOHNSON & JOHNSON	27.22x	6.26x	17.02x	2.1%	613B
ABBVIE INC.	32.17x	7.47x	15.29x	2.73%	448B
ROCHE HOLDING AG	17.9x	4.45x	10.94x	2.98%	332B
ASTRAZENECA PLC	23.72x	4.94x	14x	1.76%	293B
NOVARTIS AG	21.69x	5.59x	13.51x	2.83%	286B
NOVO NORDISK A/S	14.19x	5.21x	10.72x	3.54%	215B
AMGEN INC.	23.3x	6.21x	10.84x	2.81%	193B
GILEAD SCIENCES, INC.	-45.82x	5.53x	30.47x	2.54%	159B
Average	17.77x	6.71x	16.82x	2.19%	374.08B
Weighted average by Cap.	24.56x	7.97x	18.35x	1.91%